Heidelberg Pharma AG (LTS:0QW5) Capex-to-Revenue : 0.18 (As of Aug. 2024)

Heidelberg Pharma AG Capex-to-Revenue Chart

Heidelberg Pharma AG Annual Data
	Trend	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
Capex-to-Revenue		Get a 7-Day Free Trial					0.13	0.17	0.79	0.03	0.10

Heidelberg Pharma AG Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Capex-to-Revenue	Get a 7-Day Free Trial															0.05	0.01	0.03	0.02	0.18

Competitive Comparison of Heidelberg Pharma AG's Capex-to-Revenue

For the Biotechnology subindustry, Heidelberg Pharma AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heidelberg Pharma AG's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's Capex-to-Revenue falls into.

Heidelberg Pharma AG Capex-to-Revenue Calculation

Heidelberg Pharma AG's Capex-to-Revenue for the fiscal year that ended in Nov. 2023 is calculated as

Heidelberg Pharma AG's Capex-to-Revenue for the quarter that ended in Aug. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heidelberg Pharma AG  (LTS:0QW5) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Heidelberg Pharma AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Heidelberg Pharma AG Business Description